What type of study is this?

This is a Human Clinical Trial study.

What question did this study set out to answer?

Examine the role of retinoblastoma in informing strategies for addressing early-onset cancers.

December 10, 2025Clinical Cancer Research

Abstract A015: Retinoblastoma points to solutions for Early-Onset Cancers

View Full Paper

Ask AI

Bookmark

Examine the role of retinoblastoma in informing strategies for addressing early-onset cancers.
Analyzed the survival outcomes of retinoblastoma patients across different income settings.
Conducted a clinical trial with Chemoplaque using topotecan targeting the eye.
Utilized SwimmerMatch analysis for comparing trial participants to matched patients.
In high-income countries, over 95% survival rate for children with retinoblastoma and useful vision.
In low-income settings, survival drops to 30% with often poor vision.
The trial with topotecan showed a significant p-value of 0.0002 in favor of recurrence-free eye survival.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observations highlight improved recurrence-free eye survival with topotecan in retinoblastoma, suggesting new interventions could lower early onset cancer incidence.

Cite This Study

Gallie et al. (2025) studied this question.

synapsesocial.com/papers/69401d412d562116f28f84c4 https://doi.org/10.1158/1557-3265.earlyonsetca25-a015

View Full Paper

Ask AI

Bookmark

Implication

Observations highlight improved recurrence-free eye survival with topotecan in retinoblastoma, suggesting new interventions could lower early onset cancer incidence.

Abstract A015: Retinoblastoma points to solutions for Early-Onset Cancers

Key Points

Discussion

Implication

Cite This Study

Abstract A015: Retinoblastoma points to solutions for Early-Onset Cancers

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider